We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Instem Enters Early Phase Clinical Market

News   May 14, 2013

 
Instem Enters Early Phase Clinical Market
 
 
 

RELATED ARTICLES

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

Smelling the Forest, Not the Trees

News

Animals are much better at smelling a complex “soup” of odorants rather than a single pure ingredient, a new study by the University of Sussex has revealed.

READ MORE

Identifying Different Types of Cancer Cells Using AI

News

In a major advance that could signal a new era in cancer diagnosis and treatment, a team have shown how these problems can be overcome through an artificial intelligence-based system that can identify different types of cancer cells simply by scanning microscopic images.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE